2019 - IHE

Persson E, Persson S, Gerdtham U-G and Steen Carlsson K for the Swedish Childhood Diabetes Study Group Effect of Type 1 Diabetes on School Performance in a Dynamic World: New Analysis Exploring Swedish Register Data Applied Economics, 2019;51(24):2606-22
DOI: 10.1080/00036846.2018.1558347
Korlén S, Amer-Wåhlin I, Lindgren P & von Thiele Schwarz U Exploring staff experience of economic efficiency requirements in health care: A mixed method study The International Journal of Health Planning and Management, 2019;34(4):1439-55
DOI: 10.1002/hpm.2813
Landfeldt E, Mayhew A, Straub V, Bushby K, Lochmüller H & Lindgren P Psychometric properties of the Zarit Caregiver Burden Interview administered to caregivers to patients with Duchenne muscular dystrophy: a Rasch analysis Disability and Rehabilitation 2019; 41(8): 966-973
DOI: 10.1080/09638288.2017.1416501
Jönsson B, Kobelt G, Motlagh A, Wilking U & Wilking N An assessment of breast cancer and its management in Iran Lund, Sweden: IHE Report 2019:3
Willis M, Asseburg C, Nilsson A, & Neslusan C Challenges and Opportunities Associated with Incorporating New Evidence of Drug-Mediated Cardioprotection in the Economic Modeling of Type 2 Diabetes: A Literature Review Diabetes Therapy 2019;10(5):1753-1769
DOI: 10.1007/s13300-019-00681-4
Osooli M, Donfield S M, Steen Carlsson K, Baghaei F, Holmström M, Berntorp E & Astermark J Joint comorbidities among Swedish carriers of haemophilia: A register-based cohort study over 22 years Haemophilia: the Official Journal of the World Federation of Hemophilia, 2019;25(5):845-50
DOI: https://doi.org/10.1111/hae.13831
Berdud M, Wallin-Bernhardsson N, Zamora B, Lindgren P & Towse, A Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in Sweden and the UK: The Case of Risperidone OHE Research Paper
July 2019
Office of Health Economics, 2019
Althin R, Färe R, Gralén K, Grosskopf S, Jönsson B & Wilking N Efficiency and productivity of cancer care in Europe Journal of Cancer Policy, 2019;21:100194
DOI: https://doi.org/10.1016/j.jcpo.2019.100194
Kent, S. Becker, F. Feenstra, T. Tran-Duy, A. Schlackow, I. Tew, M. Zhang, P. Ye, W. Lizheng, S. Herman, W. McEwan, P. Schramm, W. Gray, A. Leal, J. Lamotte, M. Willis, M. Palmer, A. J. Clarke, P. The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood PharmacoEconomics, 2019.
DOI: 10.1007/s40273-019-00825-1
ePUB date: 2019/07/28
Fonorow G, van Hout B, Villa G, Arellano J, Lindgren P Updated Cost-effectiveness Analysis of Evolocumab in Patients With Very High-risk Atherosclerotic Cardiovascular Disease JAMA Cardiology, 2019;4(7):691-5
DOI:10.1001/jamacardio.2019.1647